SAiL: remarkable efficacy results in the overall population
SAiL: efficacy12
Reprinted with the kind permission of the author.
- Final efficacy outcomes further confirm the benefit of Avastin used in combination with a wide range of chemotherapy regimens.
- In the overall trial population
- median OS was 14.6 months
- median TTP was 7.8 months.
- Disclaimer: Avastin.net is a comprehensive resource for healthcare professionals outside the US. If you are a US resident please visit www.avastin.comThe information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.